Biogen Inc Stock Technical Analysis
| BIIB Stock | USD 195.55 0.97 0.49% |
As of the 17th of February 2026, Biogen shows the Downside Deviation of 2.02, risk adjusted performance of 0.1403, and Mean Deviation of 1.54. Biogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biogen Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biogen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiogenBiogen's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Biogen Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 205.52 | Buy | 37 | Odds |
Most Biogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biogen Inc, talking to its executives and customers, or listening to Biogen conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. Projected growth potential of Biogen fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biogen assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.192 | Earnings Share 8.78 | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
Biogen Inc's market price often diverges from its book value, the accounting figure shown on Biogen's balance sheet. Smart investors calculate Biogen's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Biogen's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Biogen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biogen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biogen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biogen.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Biogen on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Biogen Inc or generate 0.0% return on investment in Biogen over 90 days. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative di... More
Biogen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biogen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.02 | |||
| Information Ratio | 0.1444 | |||
| Maximum Drawdown | 12.2 | |||
| Value At Risk | (2.84) | |||
| Potential Upside | 4.38 |
Biogen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biogen's standard deviation. In reality, there are many statistical measures that can use Biogen historical prices to predict the future Biogen's volatility.| Risk Adjusted Performance | 0.1403 | |||
| Jensen Alpha | 0.3622 | |||
| Total Risk Alpha | 0.2422 | |||
| Sortino Ratio | 0.1576 | |||
| Treynor Ratio | (25.47) |
Biogen February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1403 | |||
| Market Risk Adjusted Performance | (25.46) | |||
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.72 | |||
| Downside Deviation | 2.02 | |||
| Coefficient Of Variation | 593.57 | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.87 | |||
| Information Ratio | 0.1444 | |||
| Jensen Alpha | 0.3622 | |||
| Total Risk Alpha | 0.2422 | |||
| Sortino Ratio | 0.1576 | |||
| Treynor Ratio | (25.47) | |||
| Maximum Drawdown | 12.2 | |||
| Value At Risk | (2.84) | |||
| Potential Upside | 4.38 | |||
| Downside Variance | 4.09 | |||
| Semi Variance | 2.95 | |||
| Expected Short fall | (1.69) | |||
| Skewness | 0.62 | |||
| Kurtosis | 2.41 |
Biogen Inc Backtested Returns
Biogen appears to be very steady, given 3 months investment horizon. Biogen Inc secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Biogen Inc, which you can use to evaluate the volatility of the firm. Please makes use of Biogen's Mean Deviation of 1.54, risk adjusted performance of 0.1403, and Downside Deviation of 2.02 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Biogen holds a performance score of 9. The firm shows a Beta (market volatility) of -0.0142, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biogen are expected to decrease at a much lower rate. During the bear market, Biogen is likely to outperform the market. Please check Biogen's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether Biogen's price patterns will revert.
Auto-correlation | -0.15 |
Insignificant reverse predictability
Biogen Inc has insignificant reverse predictability. Overlapping area represents the amount of predictability between Biogen time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biogen Inc price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Biogen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 97.75 |
Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biogen Inc Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biogen Inc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Biogen Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biogen Inc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biogen Inc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biogen Inc price pattern first instead of the macroeconomic environment surrounding Biogen Inc. By analyzing Biogen's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biogen's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biogen specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.00228 | 0.002822 | Price To Sales Ratio | 2.63 | 2.5 |
Biogen February 17, 2026 Technical Indicators
Most technical analysis of Biogen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biogen from various momentum indicators to cycle indicators. When you analyze Biogen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1403 | |||
| Market Risk Adjusted Performance | (25.46) | |||
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.72 | |||
| Downside Deviation | 2.02 | |||
| Coefficient Of Variation | 593.57 | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.87 | |||
| Information Ratio | 0.1444 | |||
| Jensen Alpha | 0.3622 | |||
| Total Risk Alpha | 0.2422 | |||
| Sortino Ratio | 0.1576 | |||
| Treynor Ratio | (25.47) | |||
| Maximum Drawdown | 12.2 | |||
| Value At Risk | (2.84) | |||
| Potential Upside | 4.38 | |||
| Downside Variance | 4.09 | |||
| Semi Variance | 2.95 | |||
| Expected Short fall | (1.69) | |||
| Skewness | 0.62 | |||
| Kurtosis | 2.41 |
Biogen February 17, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biogen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 32,851 | ||
| Daily Balance Of Power | (0.14) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 196.83 | ||
| Day Typical Price | 196.40 | ||
| Price Action Indicator | (1.76) |
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |